Where the Comment is King

THE NEWS COMMENTER

VOTE  (0)  (0)

Drugmakers seek FDA emergency authorization for molnupiravir, antiviral pill to treat COVID-19: Latest updates

Added 10-11-21 03:04:02pm EST - “Merck & Co. and Ridgeback Biotherapeutics announced Monday they've requested emergency use authorization to the FDA for molnupiravir. COVID updates.” - News.yahoo.com

CLICK TO SHARE

Posted By TheNewsCommenter: From News.yahoo.com: “Drugmakers seek FDA emergency authorization for molnupiravir, antiviral pill to treat COVID-19: Latest updates”. Below is an excerpt from the article.

Pharmaceutical companies Merck & Co. and Ridgeback Biotherapeutics announced Monday they requested emergency use authorization to the Food and Drug Administration for molnupiravir, an antiviral drug that offers the promise that COVID-19 could soon be treated by a pill.

Molnupiravir, an orally ingested antiviral pill, is used to treat mild to moderate adult cases of COVID-19 that are at risk of worsening to severe COVID-19 or hospitalization, according to the companies. It was created by researchers at Emory University in Atlanta and is given as four pills taken twice a day for five days.

An interim analysis from a clinical trial found the antiviral medicine reduced the risk of hospitalization or death by approximately 50%.

Since early in the pandemic, public health officials have hoped for effective antivirals that could help prevent severe infection in people exposed to the SARS-CoV-2 virus. Several existing drugs were tested against the virus early on but shown to have no benefit for patients.

In June, the Biden administration allocated $3.2 billion toward the development of an antiviral, saying the drugs would be a crucial part of the fight against the virus.

Read more...

If you don't see any comments yet, congrats! You get first comment. Be nice and have fun.

CLICK TO SHARE

BACK TO THE HOME-PAGE